Skip to main content
Clinical Trials/NCT00722059
NCT00722059CompletedPhase 1

Assessment of Emerging Technology: Comparison of Breast Tomosynthesis and Digital Mammography in the Evaluation of Heterogeneously Dense and Extremely Dense Breasts

University of Michigan1 site in 1 country50 target enrollmentStarted: April 1, 2006Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
Measure of digital tomosynthesis and digital mammography test performance.

Study Overview

Brief Summary

The purpose of this study is to compare 3D mammography with digital mammography in women with dense breasts for the detection and evaluation of masses and/or breast cancer.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
30 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Females 30 years of age or older.
  • •Dense Breasts.
  • •Has undergone clinical two view mammogram and diagnostic breast imaging evaluation.
  • •Suspicious or palpable mass and scheduled for biopsy.

Exclusion Criteria

  • •Pregnant or lactating women.
  • •Prior personal history of breast cancer.
  • •Prior breast augmentation with implants or silicon injection. male patients.
  • •No two view mammogram as part of breast imaging evaluation.
  • •Breast density of almost entirely fatty/scattered fibroglandular densities.

Arms & Interventions

1

Experimental

Subjects will undergo a 3D breast Tomosynthesis imaging scan. This is a one time breast imaging scan will last approximately 15 minutes.

Intervention: Breast Tomosynthesis (Procedure)

Outcomes

Primary Outcomes

Measure of digital tomosynthesis and digital mammography test performance.

Time Frame: 3 weeks

Interest of sensitivity, specificity and area under region of concern curve for malignant mass detection. During review, the number of masses and location and size of each mass will be recorded. An additional estimate of probability of malignancy will be recorded for each image sets.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Alexis V. Nees M.D.

Principal Investigator

University of Michigan

Study Sites (1)

Loading locations...

Similar Trials